Drugs and Other Substances With Potential to Impair BP Control S5.4.1-1. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154 83. S5.4.1-2. Grossman E, Messerli FH. Drug-induced hypertension: an unappreciated cause of secondary hypertension. Am J Med. 2012;125:14 22. S5.4.1-3. Ong SLH, Whitworth JA. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Endocrinol Metab Clin North Am. 2011;40: 393 407; ix. S5.4.1-4. Rossi GP, Seccia TM, Maniero C, et al. Drug-related hypertension and resistance to antihypertensive treatment: a call for action. J Hypertens. 2011;29:2295 309. S5.4.1-5. Tachjian A, Maria V, Jahangir A. Use of herbal products and poten- tial interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55:515 25. S5.4.1-6. Grossman E, Messerli FH. Secondary hypertension: interfering substances. J Clin Hypertens (Greenwich). 2008;10:556 66. S5.4.1-7. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare profes- sionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517 84. S5.4.1-8. Cortese S, Holtmann M, Banaschewski T, et al. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry. 2013;54:227 46. S5.4.1-9. Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of atten- tion-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007 22. S5.4.1-10. Newcomer JW. Metabolic considerations in the use of antipsy- chotic medications: a review of recent evidence. J Clin Psychiatry. 2007;68(suppl 1):20 7. S5.4.1-11. Willey JZ, Moon YP, Kahn E, et al. Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study. J Am Heart Assoc. 2014;3: e001106. S5.4.1-12. 